Zhang, G.; Xie, F.; Sun, Y.; Yu, X.; Xiao, Z.; Fang, R.; Li, J.; Li, Q.; Du, L.; Jin, Y.
Inhalable Jojoba Oil Dry Nanoemulsion Powders for the Treatment of Lipopolysaccharide- or H2O2-Induced Acute Lung Injury. Pharmaceutics 2021, 13, 486.
https://doi.org/10.3390/pharmaceutics13040486
AMA Style
Zhang G, Xie F, Sun Y, Yu X, Xiao Z, Fang R, Li J, Li Q, Du L, Jin Y.
Inhalable Jojoba Oil Dry Nanoemulsion Powders for the Treatment of Lipopolysaccharide- or H2O2-Induced Acute Lung Injury. Pharmaceutics. 2021; 13(4):486.
https://doi.org/10.3390/pharmaceutics13040486
Chicago/Turabian Style
Zhang, Guoli, Fei Xie, Yunbo Sun, Xiang Yu, Zhimei Xiao, Rongzhen Fang, Jingfei Li, Qian Li, Lina Du, and Yiguang Jin.
2021. "Inhalable Jojoba Oil Dry Nanoemulsion Powders for the Treatment of Lipopolysaccharide- or H2O2-Induced Acute Lung Injury" Pharmaceutics 13, no. 4: 486.
https://doi.org/10.3390/pharmaceutics13040486
APA Style
Zhang, G., Xie, F., Sun, Y., Yu, X., Xiao, Z., Fang, R., Li, J., Li, Q., Du, L., & Jin, Y.
(2021). Inhalable Jojoba Oil Dry Nanoemulsion Powders for the Treatment of Lipopolysaccharide- or H2O2-Induced Acute Lung Injury. Pharmaceutics, 13(4), 486.
https://doi.org/10.3390/pharmaceutics13040486